Navigation Links
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Date:3/23/2017

SANTA BARBARA, Calif. and INDIANAPOLIS, March 23, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care.

"The tremendous burden of diabetes and cardiovascular disease bears a disproportionate weight on Latino families in the United States," said David Kerr, M.D., FRCPE, director of Innovation and Research for the William Sansum Diabetes Center. "This collaboration with Lilly will allow us to gain a better understanding of how we can help these families."

Dr. Kerr added that Latino people comprise 43% of the total population in Santa Barbara County, and rates of cardio-metabolic disease are persistently higher than in the rest of the population due to a combination of factors beyond biological risk, including economics, culture and education.

For Lilly, the collaboration will provide valuable insights into patients' unmet needs and aid in the development of interventions that could improve health outcomes for Latino people.

"This is a great opportunity for us to further understand the significant impact of diabetes for Latino families," said Dara Schuster, M.D., senior director of U.S. Medical Affairs for Lilly Diabetes. "Through this collaboration, we will learn where the gaps are so we can develop meaningful solutions for the unmet needs."

About William Sansum Diabetes Center The William Sansum Diabetes Center has been on the cutting edge of diabetes research, clinical care, and education since its founding in 1944 by Dr. William Sansum, the first U.S. physician to administer insulin in the treatment of diabetes. The Center has developed new technologies and produced groundbreaking diabetes treatments, such as the artificial pancreas automating delivery of insulin to patients and new protocols for the management of pregnancies complicated by diabetes. Today, the Center has international recognition for research and innovation in the creation, development, and application of novel and effective smart technologies. The Center is committed to developing effective approaches to the education of clinicians, people with diabetes and their families, and healthcare providers in partnership with academic institutions, specialist diabetes centers, and primary care colleagues. For more information, please visit www.sansum.org.

About Lilly Diabetes Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a wide range of therapies and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com or follow us on Twitter: @LillyDiabetes.

About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/newsroom/social-channels.


Refer to:

David Kerr, MD

Julie WilliamsWilliam Sansum Diabetes Center

Eli Lilly and Companydkerr@sansum.org

williamsju@lilly.com (805) 682-7640 Ext. 241

(317) 627-4056


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Lilly To Present At Leerink Partners Global Healthcare Conference
2. Lilly Revises Time for Conference Call for Fourth-Quarter 2016 Financial Results Announcement
3. Lilly Announces Dividend Increase
4. Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimers Disease (CTAD) 2016 Meeting
5. Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A
6. Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer
7. Lilly Confirms Date and Conference Call for 2017 Financial Guidance Announcement
8. Drug Makers Stocks Under Scanner -- Eli Lilly, Provectus Biopharma, GlaxoSmithKline, and Novartis
9. Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
10. Global Diabetic Care Market to Reach $122 Billion by 2022 - Key Vendors are GlaxosmithKline, Abbott Laboratories & Eli Lilly And Company
11. Lilly to Participate in Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... ... ... Shady Grove Fertility (SGF), a nationally recognized fertility and IVF ... countries around the world, announced today it’s expanding its program for Mandarin-speaking patients and ... see Mandarin and English-speaking patients in Rockville, MD and K-Street Washington, ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... Annual Meeting April 1 to 4, 2019, at the Hyatt Regency in Chicago. ... speaking as well as 4,200-plus attendees. In attendance will be the top C-suite ...
(Date:12/10/2018)... ... December 10, 2018 , ... Parkstone Growth Partners ... of Parkview Dental Partners (“Parkview Dental”), a dentist-founded dental growth and management partnership. ... Dental, a group dental practice comprised of 16 dentists and hygienists across eight ...
Breaking Medicine Technology:
(Date:12/13/2018)... ... December 13, 2018 , ... Ross A. Clevens, MD, ... Hall of Fame, an honor recognizing the highest-rated and most active doctors on ... medical aesthetic providers. Dr. Clevens has been named a “Distinguished Inductee,” a distinction reserved ...
(Date:12/13/2018)... (PRWEB) , ... December 13, 2018 , ... ... designed to appear more modern and approachable in their community. Delia Associates created ... to provide treatment for those dealing with substance abuse in the greater Hunterdon ...
(Date:12/13/2018)... , ... December 13, 2018 , ... ... West Penn Hospital, and Westfield Memorial Hospital, all part of Allegheny Health Network ... Healthcare Information Management Executives (CHIME). , Most Wired® is the industry-leading survey on ...
(Date:12/10/2018)... , ... December 10, 2018 , ... In the aftermath ... situation has more recently been reinforced by the Me Too movement. To redress the ... set their inner Man free and become the Men they were always meant to ...
(Date:12/10/2018)... Fla. (PRWEB) , ... December 10, 2018 , ... ... Hospital Palm Harbor Emergency Room and Florida Hospital Wesley Chapel recently received the ... the category of patient experience. The award for both emergency and inpatient services ...
Breaking Medicine News(10 mins):